Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive data dive reveals hidden patterns in common eye diseases

NCT ID NCT07308639

Recruiting now Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 23 times

Summary

This study looks at health records from 50,000 people in Germany to find out how common three eye diseases—nAMD, DME, and RVO—are and how they've changed from 2009 to 2024. Researchers will compare two large data sources to see trends and what factors like age or other health issues might play a role. The goal is to better understand these conditions and how they are treated, not to test a new drug or cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Multiple

    RECRUITING

    Locations, Germany, Germany

Conditions

Explore the condition pages connected to this study.